1. Home
  2. GDHG vs CRVO Comparison

GDHG vs CRVO Comparison

Compare GDHG & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golden Heaven Group Holdings Ltd.

GDHG

Golden Heaven Group Holdings Ltd.

HOLD

Current Price

$1.13

Market Cap

34.9M

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.45

Market Cap

39.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDHG
CRVO
Founded
2008
2001
Country
China
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
39.3M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
GDHG
CRVO
Price
$1.13
$3.45
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
310.9K
14.6M
Earning Date
07-11-2025
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$2.13
52 Week High
$8.69
$13.13

Technical Indicators

Market Signals
Indicator
GDHG
CRVO
Relative Strength Index (RSI) 34.83 50.91
Support Level N/A $2.47
Resistance Level $2.06 $4.82
Average True Range (ATR) 0.26 0.93
MACD -0.06 0.06
Stochastic Oscillator 0.00 22.71

Price Performance

Historical Comparison
GDHG
CRVO

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: